Browse News
Filter News
Found 16 articles
-
Amid the dual crises of worsening medicine quality and growing drug shortages, the FDA plans to increase inspections of Indian manufacturing facilities this year, Reuters reported Tuesday.
-
With manufacturing issues persisting, last year’s shortages of medicines, including chemotherapies, weight-loss drugs and antibiotics, will continue into 2024.
-
Pharvaris Provides Business Update and Outlines 2024 Strategic Priorities
1/5/2024
Pharvaris, a clinical-stage company developing novel, oral bradykinin B2 receptor antagonists to treat and prevent hereditary angioedema attacks, provided business updates and outlined its strategic priorities for 2024.
-
Lupin Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Four Lots of Quinapril Tablets due to potential presence of N-Nitroso-Quinapril Impurity
12/21/2022
Lupin Pharmaceuticals Inc. is voluntarily recalling four (4) lots of Quinapril Tablets to the patient (consumer/user) level due to the presence of a nitrosamine impurity, N-Nitroso-Quinapril, observed in recent testing above the Acceptable Daily Intake (ADI) level.
-
Pfizer issued a statement on Monday regarding a voluntary recall of three of its products. The recall affects eleven lots of hypertension medications in total.
-
Advisory - Pfizer recalls Accuretic blood pressure tablets due to a nitrosamine impurity
3/3/2022
Pfizer Canada ULC is recalling all lots of Accuretic medication in 10/12.5 mg, 20/12.5 mg and 20/25 mg strengths due to the presence of a nitrosamine impurity above the acceptable level.
-
Prils Market: Rise in incidence of cardiovascular diseases is expected to drive the market
1/9/2022
Advancements in the pharmaceutical industry has played an integral role in the growth of the global prils market.
-
Ranbaxy Laboratories Says Gets US Nod for Blood Pressure Drug
3/5/2009
-
Pfizer Inc. and Ranbaxy Laboratories Settle Lipitor Patent Dispute; Generic Lipitor to be Launched Nov. 2011
6/18/2008
-
Par Pharmaceutical Companies, Inc. Reports Fourth Quarter and Full Year 2007 Results
3/4/2008
-
Par Pharmaceutical, Inc. Reports Third-Quarter 2007 Results
12/20/2007
-
Teva Pharmaceutical Industries Limited Announces Approval of Generic Accupril(R) Tablets
8/27/2007
-
Mylan Laboratories Inc. Announces Launch of Quinapril Tablets, USP and Quinapril Hydrochloride and Hydrochlorothiazide
2/28/2007
-
Lupin Pharmaceuticals, Inc. Receives Final Approval For Quinapril Tablets
6/26/2006
-
Court Of Appeals Upholds Preliminary Injunction Against Ranbaxy Laboratories, Enjoining Company From Marketing Quinapril HCl Tablets
11/23/2005
-
Appeals Court Upholds Preliminary Injunction Against TEVA Pharmaceuticals USA And Ranbaxy Pharmaceuticals Inc., In Generic Quinapril Patent Case
11/23/2005